A new publication involving insulin degludec related research was released on August 14, 2026. The paper, titled "Efficacy and safety of insulin icodec compared with insulin efsitora in patients with type 2 diabetes: a systematic review and network meta-analysis," appeared in Frontiers in Endocrinology.
The publication is described as a systematic review and network meta-analysis, a study design that pools and compares data across multiple existing trials. It examines insulin icodec and insulin efsitora in patients with type 2 diabetes.
No specific findings, efficacy results, or safety conclusions were provided beyond the publication title and journal listing. The article is indexed under PubMed ID 42666211 for readers seeking the full text.
This brief reports only that the publication exists and where it appeared, consistent with the available record. Readers interested in the broader context of insulin degludec, including its regulatory status and how it relates to other basal insulin therapies, can consult the compound overview for additional background.